Citation

Bateman DN. Br. J. Clin. Pharmacol. 2015; 80(1): 45-50.

Affiliation

Honorary Professor of Clinical Toxicology, Pharmacology and Toxicology, University of Edinburgh, Edinburgh, UK.

Copyright

(Copyright © 2015, John Wiley and Sons)

DOI

10.1111/bcp.12604

PMID

26099917

Abstract

Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.

Language: en